Teleflex (TFX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Teleflex Revenue Highlights


Latest Revenue (Y)

$2.97B

Latest Revenue (Q)

$764.38M

Main Segment (Y)

Vascular Access

Main Geography (Y)

Americas Segment

Teleflex Revenue by Period


Teleflex Revenue by Year

DateRevenueChange
2023-12-31$2.97B6.57%
2022-12-31$2.79B-0.66%
2021-12-31$2.81B10.74%
2020-12-31$2.54B-2.24%
2019-12-31$2.60B6.00%
2018-12-31$2.45B14.07%
2017-12-31$2.15B14.90%
2016-12-31$1.87B3.22%
2015-12-31$1.81B-1.64%
2014-12-31$1.84B8.46%
2013-12-31$1.70B9.37%
2012-12-31$1.55B1.45%
2011-12-31$1.53B-15.14%
2010-12-31$1.80B-4.67%
2009-12-31$1.89B-21.93%
2008-12-31$2.42B25.16%
2007-12-31$1.93B-26.92%
2006-12-31$2.65B5.26%
2005-12-25$2.51B1.17%
2004-12-26$2.49B8.89%
2003-12-28$2.28B9.93%
2002-12-29$2.08B8.99%
2001-12-31$1.91B7.96%
2000-12-31$1.76B10.20%
1999-12-26$1.60B11.37%
1998-12-27$1.44B25.47%
1997-12-28$1.15B23.05%
1996-12-29$931.20M2.03%
1995-12-31$912.70M12.30%
1994-12-25$812.70M21.88%
1993-12-26$666.80M-

Teleflex generated $2.97B in revenue during NA 2023, up 6.57% compared to the previous quarter, and up 121.49% compared to the same period a year ago.

Teleflex Revenue by Quarter

DateRevenueChange
2024-09-29$764.38M1.96%
2024-06-30$749.69M1.60%
2024-03-31$737.85M-4.66%
2023-12-31$773.91M3.69%
2023-10-01$746.39M0.42%
2023-07-02$743.26M4.55%
2023-04-02$710.93M-6.21%
2022-12-31$758.00M10.37%
2022-09-25$686.79M-2.52%
2022-06-26$704.54M9.79%
2022-03-27$641.72M-15.78%
2021-12-31$761.91M8.81%
2021-09-26$700.25M-1.85%
2021-06-27$713.47M12.55%
2021-03-28$633.92M-10.86%
2020-12-31$711.18M13.19%
2020-09-27$628.30M10.80%
2020-06-28$567.03M-10.09%
2020-03-29$630.64M-7.39%
2019-12-31$680.95M5.03%
2019-09-29$648.32M-0.64%
2019-06-30$652.51M6.34%
2019-03-31$613.58M-4.37%
2018-12-31$641.62M5.24%
2018-09-30$609.67M-0.03%
2018-07-01$609.87M3.85%
2018-04-01$587.23M-1.32%
2017-12-31$595.11M11.30%
2017-10-01$534.70M1.15%
2017-07-02$528.61M8.35%
2017-04-02$487.88M-5.07%
2016-12-31$513.93M12.79%
2016-09-25$455.65M-3.78%
2016-06-26$473.55M11.45%
2016-03-27$424.89M-12.30%
2015-12-31$484.50M9.19%
2015-09-27$443.71M-1.84%
2015-06-28$452.05M5.27%
2015-03-29$429.43M-9.79%
2014-12-31$476.01M4.12%
2014-09-28$457.17M-2.34%
2014-06-29$468.11M6.74%
2014-03-30$438.55M-2.66%
2013-12-31$450.54M8.88%
2013-09-29$413.80M-1.49%
2013-06-30$420.06M1.99%
2013-03-31$411.88M-1.71%
2012-12-31$419.06M13.86%
2012-09-30$368.05M-3.99%
2012-07-01$383.33M-1.14%
2012-04-01$387.76M-5.82%
2011-12-31$411.73M10.71%
2011-09-25$371.89M-4.96%
2011-06-26$391.29M0.68%
2011-03-27$388.66M-18.32%
2010-12-31$475.84M7.41%
2010-09-26$442.99M-4.05%
2010-06-27$461.68M5.78%
2010-03-28$436.46M-15.25%
2009-12-31$515.00M11.60%
2009-09-27$461.48M-4.47%
2009-06-28$483.06M2.85%
2009-03-29$469.68M-21.26%
2008-12-31$596.46M0.10%
2008-09-28$595.88M-4.52%
2008-06-29$624.09M3.24%
2008-03-30$604.52M-978.76%
2007-12-31$-68.79M-

Teleflex generated $764.38M in revenue during Q3 2024, up 1.96% compared to the previous quarter, and up 102.84% compared to the same period a year ago.

Teleflex Revenue Breakdown


Teleflex Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Anesthesia$389.96M$388.89M$380.14M$302.29M$338.41M
Surgical$427.36M$392.92M$377.76M$317.20M$370.07M
Vascular Access$708.04M$683.61M$700.24M$657.70M$600.87M
Other$291.90M$285.15M$336.58M$367.26M$347.27M
Interventional$511.43M$445.02M$427.50M$382.44M$427.56M
Interventional Urology$319.79M$322.83M$341.66M$290.02M$290.45M
Oem-$272.62M$245.68M$220.25M$220.72M

Teleflex's latest annual revenue breakdown by segment (product or service), as of Dec 23: Vascular Access (26.73%), Interventional (19.31%), Surgical (16.14%), Anesthesia (14.72%), Interventional Urology (12.07%), and Other (11.02%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Oct 23Jul 23Apr 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Surgical$111.75M$111.30M$105.52M$109.58M$112.81M$105.95M$99.02M$110.45M$93.12M$99.64M$89.70M$106.35M$92.83M$98.19M$80.39M$92.27M$82.22M$67.28M$75.43M$95.16M
Interventional$149.87M$141.16M$134.66M$135.67M$134.09M$124.78M$116.90M$125.08M$108.74M$114.34M$96.86M$114.94M$104.30M$112.08M$96.17M$106.73M$93.19M$82.59M$99.93M$112.71M
Interventional Urology$83.39M$83.10M$79.74M$92.97M$73.62M$77.82M$75.38M$89.15M$78.97M$79.82M$74.89M$92.95M$83.11M$92.24M$73.36M$93.91M$81.77M$40.09M$74.19M$89.14M
Anesthesia$101.15M$102.49M$96.35M$98.17M$97.61M$100.84M$93.33M$99.63M$97.61M$104.69M$86.96M$102.78M$97.07M$95.43M$84.86M$86.09M$75.65M$64.87M$75.70M$85.31M
Other$54.76M$41.70M$52.52M$68.26M$76.03M$75.95M$71.65M$73.59M$69.91M$72.14M$69.51M$84.68M$83.38M$86.84M$81.68M$98.10M$86.02M$91.41M$91.74M$89.37M
Vascular Access$180.90M$181.10M$181.35M$186.69M$169.92M$173.78M$177.65M$186.42M$167.15M$163.91M$166.13M$193.05M$175.48M$167.74M$163.97M$182.45M$160.05M$164.96M$150.26M$154.65M
Oem--$87.70M$82.31M$84.13M$77.00M$73.68M$71.29M$70.00M$57.66M$67.15M$64.08M$60.96M$53.49M$51.63M$63.39M----

Teleflex's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Vascular Access (26.53%), Interventional (21.98%), Surgical (16.39%), Anesthesia (14.84%), Interventional Urology (12.23%), and Other (8.03%).

Teleflex Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Americas Segment$1.72B----
Asia Segment$346.90M----
EMEA Segment$586.25M----
Oem$326.01M----
UNITED STATES-$1.79B$1.77B$1.57B$1.61B
Europe-$622.34M$665.00M$646.58M$652.07M
Asia And Asia Pacific-$270.75M$263.02M$230.27M$241.28M
All Other-$111.48M$112.05M$93.17M$95.77M

Teleflex's latest annual revenue breakdown by geography, as of Dec 23: Americas Segment (57.67%), EMEA Segment (19.71%), Asia Segment (11.66%), and Oem (10.96%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Oct 23Jul 23Apr 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Oem$82.56M$88.83M$87.70M$49.40M$55.83M$63.39M$54.61M$55.44M$56.43M$54.24M----------
EMEA$150.22M$147.06M$159.66M$135.65M$131.64M$156.12M$145.93M$140.52M$147.05M$154.54M----------
Asia$98.26M$87.00M$84.21M$68.21M$67.07M$53.13M$80.46M$77.86M$75.23M$60.78M----------
Americas Segment$433.33M$426.81M$406.29M$450.62M$428.21M$424.64M$411.86M$405.04M$412.74M$377.96M$417.33M$414.79M$375.49M-------
OEM Segment--$87.70M$82.31M$84.13M$77.00M$71.29M$70.00M$57.66M$64.08M$60.96M$53.49M--------
Asia Segment--$84.21M$88.34M$93.15M$86.68M$78.73M$82.03M$76.61M$69.19M$74.96M$80.60M$63.69M-------
EMEA Segment--$159.66M$152.37M$142.72M$147.81M$143.34M$128.44M$145.19M$136.91M$143.88M$157.13M$141.25M-------
Vascular North America-------------$375.04M$312.49M$358.00M$399.95M$374.49M$373.80M$344.02M

Teleflex's latest quarterly revenue breakdown by geography, as of Sep 24: Americas Segment (56.69%), EMEA (19.65%), Asia (12.86%), and Oem (10.80%).

Teleflex Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BDXBecton, Dickinson and Company$19.37B$4.99B
ALCAlcon$10.09B$2.46B
RMDResMed$4.69B$1.22B
HOLXHologic$4.03B$1.01B
COOCooper Companies$3.59B$1.00B
ATRAptarGroup$3.49B$909.29M
TFXTeleflex$2.97B$764.38M
WSTWest Pharmaceutical Services$2.95B$746.90M
NVSTEnvista$2.57B$884.70M
ICUIICU Medical$2.26B$596.46M
HAEHaemonetics$1.31B$336.17M
MMSIMerit Medical Systems$1.26B$339.85M
ANGOAngioDynamics$303.91M$67.49M

TFX Revenue FAQ


Teleflex's yearly revenue for 2023 was $2.97B, representing an increase of 6.57% compared to 2022. The company's yearly revenue for 2022 was $2.79B, representing a decrease of -0.66% compared to 2021. TFX's yearly revenue for 2021 was $2.81B, representing an increase of 10.74% compared to 2020.

Teleflex's quarterly revenue for Q3 2024 was $764.38M, a 1.96% increase from the previous quarter (Q2 2024), and a 2.41% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $749.69M, a 1.60% increase from the previous quarter (Q1 2024), and a 0.87% increase year-over-year (Q2 2023). TFX's quarterly revenue for Q1 2024 was $737.85M, a -4.66% decrease from the previous quarter (Q4 2023), and a 3.79% increase year-over-year (Q1 2023).

Teleflex's revenue growth rate for the last 3 years (2021-2023) was 5.87%, and for the last 5 years (2019-2023) was 14.61%.

Teleflex's revenue streams in c 23 are Anesthesia, Surgical, Vascular Access, Other, Interventional, and Interventional Urology. Anesthesia generated $389.96M in revenue, accounting 14.72% of the company's total revenue, up 0.27% year-over-year. Surgical generated $427.36M in revenue, accounting 16.14% of the company's total revenue, up 8.77% year-over-year. Vascular Access generated $708.04M in revenue, accounting 26.73% of the company's total revenue, up 3.57% year-over-year. Other generated $291.9M in revenue, accounting 11.02% of the company's total revenue, up 2.37% year-over-year. Interventional generated $511.43M in revenue, accounting 19.31% of the company's total revenue, up 14.92% year-over-year. Interventional Urology generated $319.78M in revenue, accounting 12.07% of the company's total revenue, down -0.94% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Teleflex was Vascular Access. This segment made a revenue of $708.04M, representing 26.73% of the company's total revenue.